Truscreen Group Limited (ASX:TRU) has disclosed a change of auditors, advising that Mr Vinay Sheoran, an audit partner conducting audits through Hall Chadwick (NSW), has retired as an auditor, with Mr Drew Townsend appointed as his replacement.
Key Points
- Mr Vinay Sheoran, an audit partner at Hall Chadwick (NSW), has retired as auditor for Truscreen Group Limited.
- Mr Drew Townsend, also conducting audits through Hall Chadwick (NSW), will replace Mr Sheoran as registered audit provider.
- The change is disclosed in compliance with Financial Markets Conduct (FMC) reporting requirements.
- The filing was authorised by the Board for filing with the NZX and ASX on 18 November 2026.
Auditor Retirement at Hall Chadwick NSW
According to the filing dated 18 November 2026, Mr Vinay Sheoran, an audit partner who conducted audits through Hall Chadwick (NSW), has retired as auditor for Truscreen Group Limited. The company disclosed the change to both the NZX and ASX simultaneously. No further details regarding the circumstances or timing of Mr Sheoran's retirement were provided in the filing beyond the confirmation that he will no longer serve as the registered audit provider for the company.
Incoming Registered Audit Provider Drew Townsend
Mr Drew Townsend, who also conducts audits through Hall Chadwick (NSW), has been named as the replacement registered audit provider for Truscreen Group Limited. The filing states the appointment is made in compliance with Financial Markets Conduct (FMC) reporting requirements. No additional details regarding Mr Townsend's commencement date or the scope of his engagement were disclosed in the filing. The change applies to Truscreen's audit arrangements as listed on both the NZX and ASX.
About Truscreen Group Limited
Truscreen Group Limited is described in the filing as a medical device company that has developed and manufactures an AI-enabled device for detecting abnormalities in cervical tissue in real-time. The company's device, TruScreen Ultra®, is registered as a primary screening device for cervical cancer screening and holds regulatory registrations across multiple jurisdictions. The filing states that in financial year 2024 alone, over 200,000 examinations were performed with the TruScreen device, based on single use sensor sales, and that over 200 devices have been installed across countries including China, Vietnam, Mexico, Zimbabwe, Russia, and Saudi Arabia.




Please wait processing your request...